Adverse Reactions to Selective Cyclooxygenase-2 Inhibitors (Coxibs)
Authors:
- Mario Sánchez-BorgesMSMario Sánchez-Borges
- Arnaldo Capriles-HulettACArnaldo Capriles-Hulett
- Fernan Caballero-FonsecaFCFernan Caballero-Fonseca
- 1 November 2004
- journal article
- review article
- Published by Wolters Kluwer Health in American Journal of Therapeutics
- Vol. 11 (6) , 494-500
Abstract
Coxibs, selective inhibitors of arachidonic acid cyclooxygenase-2, constitute a new, clinically useful therapeutic class of drugs that possess analgesic, antiinflammatory, and antipyretic properties. The drug inserts of prescription information presently provide a warning contraindicating their use in patients with aspirin-intolerant asthma and aspirin and NSAID hypersensitivity. However, according to investigations reported until now, most of those NSAID-sensitive individuals will tolerate coxibs. Careful oral challenge is useful for patient management since some cutaneous and systemic reactions of hypersensitivity, especially when sulfonamide-containing coxibs are employed, may occur.Keywords
This publication has 37 references indexed in Scilit:
- Safety of Celecoxib in Individuals Allergic to SulfonamideDrug Safety, 2003
- Intolerance Reactions due to the Selective Cyclooxygenase Type II Inhibitors Rofecoxib and CelecoxibActa Dermato-Venereologica, 2003
- Safety of a Cyclooxygenase-2 Inhibitor in Patients With Aspirin-Sensitive AsthmaChest, 2002
- Tolerability of rofecoxib in patients with cutaneous adverse reactions to nonsteroidal anti-inflammatory drugsAnnals of Allergy, Asthma & Immunology, 2002
- Tolerance of rofecoxib in patients with adverse reactions to nonsteroidal anti-inflammatory drugs (NSAIDs)Journal of Allergy and Clinical Immunology, 2002
- The safety of rofecoxib in patients with NSAID-induced urticaria and angioedemaJournal of Allergy and Clinical Immunology, 2002
- Anaphylactoid Reaction to a Cyclooxygenase-2 Inhibitor in a Patient Who Had a Reaction to a Cyclooxygenase-1 InhibitorNew England Journal of Medicine, 2001
- Anaphylaxis to celecoxibAnnals of Allergy, Asthma & Immunology, 2001
- Identification of Sulfonamide-like Adverse Drug Reactions to Celecoxib in the World Health Organization DatabaseCurrent Medical Research and Opinion, 2001
- Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid ArthritisJAMA, 2000